United BioSource Corporation Announces Acquisition of Cognitive Drug Research Ltd. (CDR) to Advance Services in Cognitive Testing in Clinical Research

BETHESDA, Md.--(BUSINESS WIRE)--United BioSource Corporation (UBC) today announced the acquisition of Cognitive Drug Research, Ltd. (CDR), the leader in computerized cognitive testing for clinical trials. The CDR System is the most widely used computerized cognitive testing system in the world: it is used in more than 1000 trials encompassing approximately 50 different disease areas, validated in over 60 languages, and cited in more than 700 publications and abstracts. Additionally, CDR maintains the industry’s largest healthy subject, patient, and drug databases of cognitive effects, providing the standard for establishing the clinical relevance of compounds.